• Reviva Pharmaceuticals (NASDAQ:RVPH) Upgraded by Roth Capital to "Strong-Buy" Rating

    المصدر: Buzz FX / 11 يناير 2025 05:56:14   America/New_York


    Reviva Pharmaceuticals (NASDAQ:RVPH) Upgraded by Roth Capital to "Strong-Buy" Rating Written by MarketBeat January 11, 2025 Share Link copied to clipboard. Reviva Pharmaceuticals ( NASDAQ:RVPH - Get Free Report ) was upgraded by research an
    Read more...
شارك على،